Cargando…
Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
British Epilepsy Association. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255220/ https://www.ncbi.nlm.nih.gov/pubmed/34252878 http://dx.doi.org/10.1016/j.seizure.2021.06.035 |
| _version_ | 1783717862887653376 |
|---|---|
| author | Moloney, Patrick B. Delanty, Norman |
| author_facet | Moloney, Patrick B. Delanty, Norman |
| author_sort | Moloney, Patrick B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8255220 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | British Epilepsy Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82552202021-07-06 Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic Moloney, Patrick B. Delanty, Norman Seizure Letter to the Editor British Epilepsy Association. Published by Elsevier Ltd. 2021-10 2021-07-05 /pmc/articles/PMC8255220/ /pubmed/34252878 http://dx.doi.org/10.1016/j.seizure.2021.06.035 Text en © 2021 British Epilepsy Association. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Moloney, Patrick B. Delanty, Norman Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic |
| title | Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic |
| title_full | Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic |
| title_fullStr | Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic |
| title_full_unstemmed | Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic |
| title_short | Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic |
| title_sort | stick or twist: everolimus for seizures in tuberous sclerosis complex during the covid-19 pandemic |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255220/ https://www.ncbi.nlm.nih.gov/pubmed/34252878 http://dx.doi.org/10.1016/j.seizure.2021.06.035 |
| work_keys_str_mv | AT moloneypatrickb stickortwisteverolimusforseizuresintuberoussclerosiscomplexduringthecovid19pandemic AT delantynorman stickortwisteverolimusforseizuresintuberoussclerosiscomplexduringthecovid19pandemic |